Skip to main content

Table 1 Study participants’ characteristics (n = 104)

From: Usefulness of day 7 lumefantrine plasma concentration as a predictor of malaria treatment outcome in under-fives children treated with artemether-lumefantrine in Tanzania

VariablesDrug givenp-value
Generic n (%)Innovator n (%) 
Age (months)
 ≤ 2425 (62.5%)15 (37.5%)0.12
 > 2430 (46.9%)34 (53.1%) 
Sex
 Female28 (57.1%)21 (42.9%)0.41
 Male27 (49.1%)28 (50.9%) 
Weight (kg)
 < 1539 (50.6%)38 (49.4%)0.44
 ≥ 1516 (59.3%)11 (40.7%) 
Baseline temperature
 < 37.5 ℃9 (52.9%)8 (47.1%)0.99
 ≥ 37.5 ℃46 (52.9%)41 (47.1%) 
Baseline hemoglobin (g/dl)
 < 1141 (56.9%)31 (43.1%)0.30
 ≥ 1112 (48%)13 (52%) 
Baseline parasitaemia (/µl)
 < 100015 (65.2%)8 (34.8%) 
 1000–10,0007 (29.2%)17 (70.8%) 
 ≥ 10,00033 (57.9%)24 (42.1%)0.025